IVOCLAR Vivadent Empress Direct Cavifil Refills

IVOCLAR Vivadent Empress Direct Cavifil Refills

Marsoni

M251S

$2150.00

Get it in 3 business days with 1 day shipping. Friday, May 29

IVOCLAR Vivadent Empress Direct Cavifil RefillsEmpress Direct Empress Direct is a light curing, highly esthetic nano hybrid composite filling material for direct restorative procedures in the anterior and posterior region. For nearly 20 years, the name IPS Empress has been associated with the highest level of esthetics in the reproduction of natural tooth characteristics. IPS Empress Direct from the IPS Empress range combines the esthetics of ceramics with the application advantages of composites.

Easy Shipping

Quick Dispatch:

Your IVOCLAR Vivadent Empress Direct Cavifil Refills orders ship within 1-2 business days.

Delivery Options:

Standard: 3-7 business days
Fast: 2-3 business days
Express: 1-2 business days

Order Tracking:

You'll receive a tracking link by email once your IVOCLAR Vivadent Empress Direct Cavifil Refills ships.

Need Help?
Questions about IVOCLAR Vivadent Empress Direct Cavifil Refills, sizing, or delivery? We're just an email away.

Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for IVOCLAR Vivadent Empress Direct Cavifil Refills in your area.

Get Shipping Estimates

Country Zip/Postal Code

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

I got these for my husband to wear with jeans or business casual dress pants. They look sharp and professional and dress up jeans if you're going out. He says they fit comfortably and he can walk on them all day without his feet hurting. They are beautiful genuine leather so they don't get stinky. I got my husband's normal size and they fit to size.

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on February 11, 2026